Aurora Cannabis Inc. closed 52.83% short of its 52-week high of $9.35, which the company reached on April 30th.
Aurora Cannabis (TSX:ACB) is expanding its pastille offerings in Australia, marking a significant step in the company’s move to diversify its range of medical cannabis products ・This expansion aims to ...
The year is a more than a month old, but Aurora Cannabis (NASDAQ: ACB) is already one of the hottest stocks to own in 2025. As of Feb. 11, the pot stock has soared more than 50% since the year ...
Hosted on MSN1mon
Aurora Cannabis jumps as medical cannabis drives Q3 beatAurora’s (NASDAQ:ACB) medical cannabis added C$68.1M to the company’s topline with ~51% YoY while its plant propagation business generated C$8.9M in net revenue with ~22% YoY rise, and ACB’s ...
Shares of Aurora Cannabis Inc. ACB shed 2.04% to $4.33 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.18% to ...
Analysts raised concerns about potential pricing impacts from increased competition in global medical cannabis markets. Martin emphasized Aurora’s competitive advantages, including regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results